Brain Tumor, Recurrent
Oncology
3
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
T-TherapeuticsUK - Cambridge
2 programs1
1
Photofrin photodynamic therapy.Phase 21 trial
PhotofrinPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
T-TherapeuticsPhotofrin photodynamic therapy.
EpicentRxRRx-001
T-TherapeuticsPhotofrin
GT BiopharmaGammaTile
Clinical Trials (4)
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Start: Jun 2015Est. completion: Dec 2017
Phase 2Terminated
RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
Start: Jan 2023Est. completion: Jul 2024
Phase 1Terminated
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Start: Mar 2013Est. completion: Jun 2018
Phase 1Completed
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Start: Sep 2020Est. completion: Dec 2028
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
2m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
2m ago
Office Administrator
SystImmune
2m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
13m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
16m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
16m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
3 companies competing in this space